STERIS plc
STE
View Detailed Chart
252.160USD
+8.345+3.42%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
24.75BMarket Cap
35.02P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.42%
5 Days
-3.98%
1 Month
-3.03%
6 Months
+13.99%
Year to Date
-0.54%
1 Year
+11.85%
View Detailed Chart
TradingKey Stock Score of STERIS plc
Currency: USD Updated: 2026-02-06Key Insights
STERIS plc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 9 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 282.20.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
STERIS plc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
STERIS plc Highlights
StrengthsRisks
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.35% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.46B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 36.04%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 36.04%.
Undervalued
The company’s latest PE is 35.02, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 94.94M shares, decreasing 2.93% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 8.31K shares of this stock.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
282.201
Target Price
+15.75%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
STERIS plc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
STERIS plc Info
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Ticker SymbolSTE
CompanySTERIS plc
CEOCarestio (Daniel A)
Websitehttps://www.steris.com/
Related Instruments
+2.98%
+0.07%
+1.60%
+2.48%
+0.31%
-1.14%
-0.05%
-2.35%
-1.78%
+2.65%
+2.59%
+2.03%
+2.01%
+2.38%
+1.74%
+0.16%
+0.78%
+1.72%
+0.59%
-2.02%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69012.060
-958.070 (-1.37%)
282.580
+22.390 (+8.61%)
2052.170
+0.440 (+0.02%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
